Related Experiment Videos
[Repeated metallic mercury intravenous injections for doping]
Zygmunt Chodorowski1, Jacek Sein Anand
1I Klinika Chorób Wewnetrznych i Ostrych Zatruć Akademii Medycznej, 80-211 Gdańsk, ul. Debinki 7.
Summary
A 24-year-old patient with unknown nephropathy intentionally overdosed on tricyclic antidepressant drugs (TLPD) and ethanol. Toxicological tests revealed high TLPD, ethanol, and significant metallic mercury levels, indicating mercury injection for performance enhancement.
Area of Science:
- Toxicology
- Nephrology
- Environmental Health
Background:
- A 24-year-old patient presented with nephropathy of unknown origin and a history of suicide attempts.
- The patient had a history of intentional overdose involving tricyclic antidepressant drugs (TLPD) and ethanol.
Observation:
- Toxicological analysis revealed elevated serum TLPD (548 µg/L) and ethanol (2.1 g/L).
- Chest X-ray identified disseminated metallic particles in the lungs, suggestive of metallic mercury.
- The patient admitted to intravenous metallic mercury injections over three years to enhance physical performance.
Findings:
- Serum mercury levels were significantly elevated at 300 µg/L.
- Urinary mercury excretion was high at 500 µg/L/24 hours.
- The patient's condition involved co-existing TLPD/ethanol toxicity and chronic metallic mercury exposure.
Implications:
- This case highlights a novel route of heavy metal exposure through self-injection for perceived performance enhancement.
- Chronic mercury exposure can lead to severe health consequences, including nephropathy and potential neurological damage.
- This case underscores the importance of comprehensive toxicological screening in patients with unexplained medical conditions and a history of substance abuse.